Intermittent fasting- the future treatment in nash patients?
Sign Up to like & getrecommendations! Published in 2023 at "Hepatology"
DOI: 10.1097/hep.0000000000000330
Abstract: Non-alcoholic steatohepatitis (NASH) is one of the leading causes of chronic liver disease with the potential of evolving towards end-stage liver disease and hepatocellular carcinoma (HCC), even in the absence of cirrhosis. Apart from becoming… read more here.
Keywords: future treatment; fasting future; patients intermittent; intermittent fasting ... See more keywords